🇺🇸 FDA
Patent

US 9421275

Oligomer-calcimimetic conjugates and related compunds

granted A61KA61K47/60A61P

Quick answer

US patent 9421275 (Oligomer-calcimimetic conjugates and related compunds) held by Nektar Therapeutics expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K47/60, A61P, A61P5/10, A61P5/20